Compared to the control group, survivors with MetS factors showed greater levels of GIP (p = 0.030), glucagon (p < 0.001), leptin (p = 0.001), PAI-1 (p = 0.009), and lower level of ghrelin (p < 0.001) (Table 4). This evidence concerns the gene LEP and metabolic syndrome.